BAC
Bank of America Corporation
BAC's fundamentals are strong: its operating margin rose 5 points to 35% and revenue grew 15%. At 12x earnings, it's trading in line with its usual 13x. Analysts expect earnings growth.
FACT
FACT II Acquisition Corp
There isn't enough reported data to score FACT yet.
BAC Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
BAC's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like BAC.
FACT Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Stable | |
| N/A | |
| N/A |
FACT's profitability is currently stable. There isn't enough data to rate its revenue. Free cash flow and net leverage aren't meaningful measures for financial services companies like FACT.
BAC PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.4x | $39.50 | -22% |
| Forward | 10x | $50.51 | — |
| Current | 12x | $50.51 | — |
| Fair | 13x | $53.81 | +6.5% |
| Expensive | 15x | $62.23 | +23% |
Historical ranges are pointers, not guarantees.
BAC's PE is in its fair range at 12x. If earnings grow as analysts expect, today's price would be 10x next year's earnings, in its cheap range.
FACT PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 49x | $8.73 | -19% |
| Fair | 53x | $9.53 | -12% |
| Current | 60x | $10.79 | — |
| Expensive | 96x | $17.29 | +60% |
Historical ranges are pointers, not guarantees.
FACT has the edge over BAC in the historical PE scenario, which offers more potential upside but is not a forecast.
BAC Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for BAC, with profitability improving.
FACT Forward outlook
There aren't enough analyst estimates for FACT to show an outlook.
BAC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $4.92 | +17% |
| Q3 2026 | $4.19 | +14% |
| Q2 2026 | $4.34 | +27% |
| Q1 2026 | $4.02 | +20% |
| Q4 2025 | $3.81 | +19% |
| Q3 2025 | $3.66 | +33% |
| Q2 2025 | $3.41 | +20% |
| Q1 2025 | $3.35 | +16% |
| Q4 2024 | $3.21 | +4.2% |
BAC has the edge over FACT on earnings, with more consistent year-over-year improvement.
FACT Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | $0.18 | -10% |
| Q2 2026 | $0.20 | +82% |
| Q1 2026 | $0.22 | +$0.82 |
| Q4 2025 | $0.22 | +$1.26 |
| Q3 2025 | $0.20 | +$3.75 |
| Q2 2025 | $0.11 | +$8.84 |
| Q1 2023 | $0.11 | +57% |
| Q4 2022 | $0.13 | +8.3% |
FACT earned $0.18 per share over the past year, down 10% from the year before.
BAC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $30B | +6.7% |
| Q2 2026 | $31.6B | +19% |
| Q1 2026 | $30.3B | +11% |
| Q4 2025 | $31.2B | +23% |
| Q3 2025 | $28.1B | +11% |
| Q2 2025 | $26.5B | +4.3% |
| Q1 2025 | $27.4B | +6% |
| Q4 2024 | $25.3B | +15% |
BAC has the edge over FACT on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 30% | -3.7 points |
| Q2 2026 | 37% | +7.6 points |
| Q1 2026 | 34% | +4.7 points |
| Q4 2025 | 40% | +12 points |
| Q3 2025 | 34% | +4.8 points |
| Q2 2025 | 29% | -0.7 points |
| Q1 2025 | 30% | +1.5 points |
| Q4 2024 | 28% | +14 points |
BAC's operating margin was 30% last quarter, down 3.7 points from the same quarter a year ago.
FACT Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q4 2024 | $94.2M | +49% |
FACT's revenue has slid since its 2024 peak: $0 last quarter.
| Quarter | Margin | YoY |
|---|---|---|
| Q4 2024 | -1% | +58 points |
| Q2 2024 | -211% | N/A |
| Q1 2024 | -75% | N/A |
| Q4 2023 | -59% | N/A |
| Q3 2023 | -45% | N/A |
FACT's operating margin was −1% last quarter, up 44 points from the same quarter a year ago.
BAC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$6.5B | -114% |
| Q2 2026 | $29B | +$38.2B |
| Q1 2026 | $41.8B | +$44B |
| Q4 2025 | -$22.9B | -189% |
| Q3 2025 | $46.9B | +$84.2B |
| Q2 2025 | -$9.1B | -150% |
| Q1 2025 | -$2.2B | +$13.4B |
| Q4 2024 | $25.9B | -21% |
BAC has the edge over FACT on cash generation, producing positive trailing cash flow while its opponent burns cash.
FACT Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$97.6K | -$16.7K |
| Q2 2026 | -$242.4K | -$108.9K |
| Q1 2026 | -$131.9K | +$94K |
| Q4 2025 | -$462.8K | -$208.7K |
| Q3 2025 | -$80.8K | -$29.8K |
| Q2 2025 | -$133.6K | -$133.6K |
| Q1 2025 | -$225.9K | +$4.7M |
| Q4 2024 | -$254.1K | -100% |
FACT's free cash flow was −$934,734 over the past year, against −$694,402 the year before. Free cash flow isn't a meaningful measure for financial services companies like FACT.
BAC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1% | -72M shares |
| 1 year | -5.3% | -405M shares |
| 3 years | -11% | -854M shares |
| 5 years | -15% | -1.3B shares |
| Available history | -24% | -2.2B shares |
BAC has the edge over FACT on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $6B |
| Q2 2026 | $6B |
| Q1 2026 | $7.2B |
| Q4 2025 | $6.3B |
| Q3 2025 | $5.3B |
| Q2 2025 | $5.3B |
| Q1 2025 | $4.5B |
| Q4 2024 | $3.5B |
BAC spent $25.6B buying back its own shares over the past year, up 37% from the year before.
FACT Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +32% | +5.8M shares |
| 1 year | +32% | +5.8M shares |
| 3 years | -39% | -15.5M shares |
| 5 years | -42% | -17.7M shares |
FACT has 24M diluted shares, up 32% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q2 2024 | — |
BAC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 6.4x | High |
| Q2 2026 | 6.7x | High |
| Q1 2026 | 7.1x | High |
| Q4 2025 | 7.7x | High |
| Q3 2025 | 8.3x | High |
| Q2 2025 | 8.8x | High |
| Q1 2025 | 8.6x | High |
| Q4 2024 | 9.0x | High |
BAC's net debt is about 6.4 years of its operating earnings (EBITDA), down from 8.3 years a year ago. Net leverage isn't a meaningful measure for financial services companies like BAC.
FACT Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2025 | -1.2x | Net Cash |
| Q1 2023 | 0.6x | Very low |
| Q4 2022 | 0.2x | Very low |
| Q3 2022 | 0.1x | Very low |
FACT has more cash than debt. Net leverage isn't a meaningful measure for financial services companies like FACT.
BAC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 37.1 | Neutral |
| Stochastic | 4.9 | Oversold |
BAC's weekly RSI is 37 (neutral) and its Stochastic is 5 (oversold).
FACT Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 76.0 | Overbought |
| Stochastic | 94.2 | Overbought |
FACT's weekly RSI is 76 (overbought) and its Stochastic is 94 (overbought).
BAC PE vs Financial Services Sector
| Metric | BAC | Sector median | Relative |
|---|---|---|---|
| PE | 12x | 13x | 7.5% below |
| PE % | 40 | 63 | 23 pts below |
BAC has the edge over FACT on valuation relative to its sector.
FACT PE vs Financial Services Sector
| Metric | FACT | Sector median | Relative |
|---|---|---|---|
| PE | 60x | 13x | 360% above |
| PE % | 80 | 22 | 58 pts above |
FACT is trading at 60x earnings, a 360% premium to the Financial Services sector's median of 13x, though its earnings don't support one.
BAC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $52.1 | 3% below |
| 20 week MA | $57.8 | 13% below |
| 50 week MA | $54.7 | 7.7% below |
| 100 week MA | $50.5 | 0% below |
| 200 week MA | $42.5 | 19% above |
FACT has stronger trend alignment. BAC is above 1 of 5 weekly averages versus FACT above 4 of 4.
FACT Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $10.8 | 0.3% above |
| 20 week MA | $10.7 | 0.7% above |
| 50 week MA | $10.6 | 1.8% above |
| 100 week MA | $10.4 | 3.9% above |
FACT is in an uptrend: it's above all four of its weekly moving averages, and 3.9% above its 100-week average.
BAC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $35.4 | $30.0 | -15% |
| 2021 | $30.0 | $44.4 | +48% |
| 2022 | $44.4 | $32.5 | -27% |
| 2023 | $32.5 | $33.7 | +3.7% |
| 2024 | $33.7 | $44.3 | +32% |
| 2025 | $44.3 | $56.2 | +27% |
| 2026 YTD | $56.2 | $50.5 | -10% |
BAC has finished higher in four of the last six years. It's down 10% so far in 2026.
FACT Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2024 | $9.88 | $9.88 | 0% |
| 2025 | $9.88 | $10.4 | +5.2% |
| 2026 YTD | $10.4 | $10.8 | +3.8% |
FACT has the edge over BAC on returns for 2026, with the stronger performance.